Trials / Completed
CompletedNCT04542876
Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection
Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection: An Open Label Feasibility Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Aarogyam UK · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The emergence of asymptomatic patients poses a significant challenge to the prevention and treatment of the epidemic.There have not been any treatment options that reduce the viral load or preventive options that reduce the risk of developing severe conditions.Therefore, present feasibility study of the safety and efficacy of Guduchi Ghan Vati was conducted in asymptomatic patients with COVID-19
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Guduchi Ghan Vati | Guduchi Ghan Vati was orally administered 2 tablets (1000 mg) twice daily for 2 weeks. |
Timeline
- Start date
- 2020-05-01
- Primary completion
- 2020-07-31
- Completion
- 2020-08-18
- First posted
- 2020-09-09
- Last updated
- 2020-09-09
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT04542876. Inclusion in this directory is not an endorsement.